DEA Controlled Substance Prescribing via Telehealth: Understanding the Ryan Haight Act and Current Waivers

Introduction

The ability to prescribe controlled substances via telehealth has been a topic of significant regulatory focus and evolution, particularly in the wake of the COVID-19 Public Health Emergency (PHE). At the core of federal regulation for telehealth prescribing of controlled substances is the Ryan Haight Online Pharmacy Consumer Protection Act of 2008. This act generally requires an in-person medical evaluation before a practitioner can prescribe controlled substances to a patient via the internet. However, various exceptions and waivers have been implemented, creating a complex regulatory landscape that healthcare providers must navigate carefully.

The Ryan Haight Act: The Baseline Requirement

Enacted to combat the proliferation of rogue online pharmacies, the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (21 U.S.C. § 802(54)) established a fundamental principle: a controlled substance prescription issued by means of the internet is not valid unless the prescribing practitioner has conducted at least one in-person medical evaluation of the patient. The intent was to ensure that a legitimate practitioner-patient relationship is established, and that the prescription serves a legitimate medical purpose, prior to the initiation of controlled substance treatment.

The Act defines